SHILPAMED.NSSHILPAMED.NSNSE
Loading
Price to Sales HistoryFair Value
Percentile Rank71
3Y CAGR+19.5%
5Y CAGR+17.5%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+19.5%/yr
vs -12.6%/yr prior
5Y CAGR
+17.5%/yr
Consistent
Acceleration
+32.1pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthFair Value
PeriodValueYoY Change
20254.98+33.5%
20243.73+95.8%
20231.90-34.8%
20222.92-3.5%
20213.02+36.2%
20202.22-43.2%
20193.91-21.9%
20185.00-26.5%
20176.80+31.4%
20165.18-